0
     

Report Added
Report already added
Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026

The global genome editing/genome engineering market is expected to reach USD 11.7 billion by 2026 from USD 5.1 billion in 2021, at a CAGR of 18.2% during the forecast period. The growth of the genome editing/genome engineering market is expected to be driven by the rise in government funding and growth in the number of genomics projects, increased application areas of genomics, and the introduction of CRISPR-Cas9 for genome engineering.

“The services segment accounted for the highest growth rate in the genome editing/genome engineering market, by product & service, during the forecast period”

In 2020, the services segment accounted for the highest growth rate. The genomic editing/genome engineering services market is segmented into sequencing services; data analysis; bioinformatics services; and other services, such as informatics, clean up, gene expression, and DNA synthesis services. Most companies in the services sector offer all these services. Although the services segment represents a major part of the market, some end users have in-house sequencing and bioinformatics capabilities. Service providers possess highly advanced and multiple sequencing platforms and make use of high-quality consumables/kits. They also have multiple sequencing platforms, which enables these service providers to choose the most appropriate system to solve the scientific challenges of their customers and promptly deliver high-quality sequencing at a low cost.

“The CRISPR segment accounted for the largest share of the application segment, by technology, in the genome editing/genome engineering”

In 2020, the CRISPR technology accounted for the largest share. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a revolutionary tool used to edit genes in a way that resembles traditional GMO techniques. The use of the Cas9 enzymes differentiates CRISPR from other forms of genetic modification. The ease of use associated with CRISPR technology gives it a significant advantage over ZFN and TALEN, especially in generating a large set of vectors to target numerous sites or even genome-wide libraries. Another potential advantage of CRISPR is its ability to use multiple guide RNA parallelly to target multiple sites simultaneously in the same cell. This makes it easier to mutate multiple genes at once or engineer precise deletions in a genomic region.

“Asia Pacific: The fastest-growing region in the genome editing/genome engineering market”

The genome editing/genome engineering market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). Increasing government support, and developing R&D infrastructure Increasing investments in research and rising number of applications of gene synthesis for genetic engineering of cells and tissues of organisms are the major factors fueling the growth of the genome editing/genome engineering market in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 70% and Demand Side 30%
•By Designation: C-level - 55%, D-level - 20%, and Others - 25%
•By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

List of Companies Profiled in the Report:
•Thermo Fisher Scientific (US)
•Merck KGaA (Germany)
•GenScript China)
•Sangamo Therapeutics (US)
•Lonza (Switzerland)
•Editas medicine (US)
•CRISPR Therapeutics
•Tecan Life sciences (Switzerland)
•Precision biosciences (US)
•Agilent technologies (Switzerland)
•PerkinElmer (US)
•Cellectis SA (France)
•Intellia Therapeutics (US)
•Bluebird Bio (US)
•Regeneron Pharmaceuticals (US)
•Synthego (US)
•Vigene Biosciences (US)
•Beam Therapeutics (US)
•Integrated DNA Technologies (US)
•New England Biolabs (US)
•Origene Technologies (US)
•Transposagen Biopharmaceuticals (US)
•Creative Biogene (US)
•Recombinetics (US)
•Caribou Biosciences (US)

Research Coverage:

This report provides a detailed picture of the genome editing/genome engineering market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genome editing/genome engineering market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.
1INTRODUCTION31
1.1OBJECTIVES OF THE STUDY31
1.2MARKET DEFINITION31
1.2.1INCLUSIONS & EXCLUSIONS31
1.3MARKET SCOPE32
1.3.1MARKETS COVERED32
1.3.2YEARS CONSIDERED FOR THE STUDY32
1.4CURRENCY33
1.5LIMITATIONS33
1.6STAKEHOLDERS33
1.7SUMMARY OF CHANGES34
2RESEARCH METHODOLOGY35
2.1RESEARCH DATA35
FIGURE 1RESEARCH DESIGN35
2.1.1SECONDARY DATA36
2.1.2PRIMARY DATA36
FIGURE 2BREAKDOWN OF PRIMARIES: GENOME EDITING/GENOME ENGINEERING MARKET37
2.2MARKET ESTIMATION METHODOLOGY37
FIGURE 3GENOME EDITING/GENOME ENGINEERING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 202037
FIGURE 4MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 202038
2.2.1INSIGHTS FROM PRIMARY EXPERTS39
FIGURE 5MARKET SIZE VALIDATION FROM PRIMARY SOURCES39
2.3MARKET GROWTH RATE PROJECTIONS40
FIGURE 6GENOME EDITING/GENOME ENGINEERING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS40
FIGURE 7GENOME EDITING/GENOME ENGINEERING MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS41
2.4DATA TRIANGULATION42
FIGURE 8DATA TRIANGULATION METHODOLOGY42
2.5RESEARCH ASSUMPTIONS42
2.5.1COVID-19 SPECIFIC ASSUMPTIONS43
2.6RISK ANALYSIS43
3EXECUTIVE SUMMARY44
FIGURE 9GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)44
FIGURE 10GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY
2021 VS. 2026 (USD MILLION)45
FIGURE 11GENOME EDITING/GENOME ENGINEERING, BY APPLICATION,
2021 VS. 2026 (USD MILLION)45
FIGURE 12GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER
2021 VS. 2026 (USD MILLION)46
FIGURE 13GEOGRAPHICAL SNAPSHOT: GENOME EDITING/GENOME ENGINEERING MARKET47
4PREMIUM INSIGHTS48
4.1GENOME EDITING/GENOME ENGINEERING MARKET OVERVIEW48
FIGURE 14GROWING INVESTMENTS IN GENOMICS RESEARCH TO DRIVE MARKET GROWTH48
4.2NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020)49
FIGURE 15REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING/GENOME ENGINEERING MARKET IN NORTH AMERICA IN 202049
4.3GENOME EDITING/GENOME ENGINEERING SHARE, BY TECHNOLOGY (2020)49
FIGURE 16THE CRISPR SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN THE GENOME EDITING/GENOME ENGINEERING MARKET IN 202049
4.4GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)50
FIGURE 17THE CELL LINE ENGINEERING SEGMENT EXPECTED TO DOMINATE THE APPLICATIONS MARKET IN 202650
4.5GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY END USER, 202050
FIGURE 18THE PHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 202050
4.6GENOME EDITING/GENOME ENGINEERING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES51
FIGURE 19ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GENOME EDITING/GENOME ENGINEERING MARKET FROM 2021 TO 202651
5MARKET OVERVIEW52
5.1INTRODUCTION52
5.2MARKET DYNAMICS52
FIGURE 20GENOME EDITING/GENOME ENGINEERING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE52
TABLE 1GENOME EDITING/GENOME ENGINEERING MARKET: IMPACT ANALYSIS53
5.2.1DRIVERS53
5.2.1.1Rise in government funding and growth in the number of genomics projects53
5.2.1.2Increased application areas of genomics54
5.2.1.3Introduction of CRISPR-Cas954
5.2.2RESTRAINTS54
5.2.2.1Off-target effects of CRISPR technology54
5.2.3OPPORTUNITIES55
5.2.3.1Extensive use of genome editing in personalized medicine55
5.2.3.2High growth prospects for the market in emerging countries55
5.2.4CHALLENGES55
5.2.4.1High equipment costs55
5.3RANGES/SCENARIOS56
FIGURE 21SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE GENOME EDITING/GENOME ENGINEERING MARKET56
5.4IMPACT OF COVID-19 OUTBREAK ON THE GENOME EDITING/GENOME ENGINEERING MARKET56
FIGURE 22GENOME EDITING/GENOME ENGINEERING SCENARIO WITH AND WITHOUT COVID-19 IMPACT. 2019-202157
5.5TRENDS/DISRUPTIONS IMPACTING BUSINESSES OF CUSTOMERS58
5.6VALUE CHAIN ANALYSIS59
FIGURE 23VALUE CHAIN ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE59
5.7TECHNOLOGICAL ANALYSIS60
5.8PATENT ANALYSIS61
FIGURE 24PATENT APPLICATIONS FOR GENETIC ENGINEERING MARKET, JANUARY 2011–OCTOBER 202161
TABLE 2INDICATIVE LIST OF PATENTS IN THE GENOME EDITING/GENOME ENGINEERING MARKET62
5.9ECOSYSTEM ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET62
FIGURE 25ECOSYSTEM ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET62
TABLE 3SUPPLY CHAIN ECOSYSTEM63
5.10PORTER’S FIVE FORCES ANALYSIS64
TABLE 4GENOME EDITING/ GENOME ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS64
5.10.1THREAT OF NEW ENTRANTS64
5.10.2THREAT OF SUBSTITUTES64
5.10.3BARGAINING POWER OF SUPPLIERS65
5.10.4BARGAINING POWER OF BUYERS65
5.10.5COMPETITIVE RIVALRY AMONG EXISTING PLAYERS65
5.11REGULATORY ANALYSIS65
5.11.1REGULATIONS FOR PRODUCTS DEVELOPED USING GENOME EDITING/GENOME ENGINEERING TECHNOLOGY65
5.11.1.1US65
TABLE 5REGULATIONS FOR PRODUCTS DEVELOPED USING GENOME EDITING/GENOME ENGINEERING TECHNIQUES66
5.11.1.2China66
6GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE68
6.1INTRODUCTION69
TABLE 6GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)69
6.2REAGENTS & CONSUMABLES69
6.2.1REAGENTS & CONSUMABLES HOLD THE LARGEST MARKET SHARE69
TABLE 7GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)69
TABLE 8NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)70
TABLE 9EUROPE: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)70
TABLE 10APAC: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)70
TABLE 11LATAM: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)71
6.3SOFTWARE & SYSTEMS71
6.3.1RISING APPLICATION OF GENOME EDITING/SEQUENCING TO INCREASE THE DEMAND FOR SYSTEMS AND SOFTWARE71
TABLE 12GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)71
TABLE 13NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)72
TABLE 14EUROPE: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)72
TABLE 15APAC: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)72
TABLE 16LATAM: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)73
6.4SERVICES73
6.4.1WIDE APPLICATION OF EDITING/GENOME ENGINEERING SERVICES TO INCREASE MARKET GROWTH73
TABLE 17GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)73
TABLE 18NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)74
TABLE 19EUROPE: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)74
TABLE 20APAC: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)74
TABLE 21LATAM: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)75
7GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY76
7.1INTRODUCTION77
TABLE 22GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)77
7.2CRISPR77
7.2.1EASE OF USE GIVES CRISPR AN ADVANTAGE OVER OTHER TECHNOLOGIES77
TABLE 23GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2019–2026 (USD MILLION)78
TABLE 24NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019–2026 (USD MILLION)78
TABLE 25EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019–2026 (USD MILLION)78
TABLE 26APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019–2026 (USD MILLION)79
TABLE 27LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2019–2026 (USD MILLION)79
7.3TALEN79
7.3.1QUICK MODIFICATIONS IN THE GENOME SEQUENCE ARE POSSIBLE WITH TALEN79
TABLE 28GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2019–2026 (USD MILLION)80
TABLE 29NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019–2026 (USD MILLION)80
TABLE 30EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019–2026 (USD MILLION)80
TABLE 31APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019–2026 (USD MILLION)81
TABLE 32LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2019–2026 (USD MILLION)81
7.4ZFN81
7.4.1EUKARYOTE CELL STUDIES DONE BY ZFN TO DRIVE MARKET GROWTH81
TABLE 33GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2019–2026 (USD MILLION)82
TABLE 34NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018–2025 (USD MILLION)82
TABLE 35EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2019–2026 (USD MILLION)82
TABLE 36APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2019–2026 (USD MILLION)83
TABLE 37LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2019–2026 (USD MILLION)83
7.5ANTISENSE83
7.5.1INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH83
TABLE 38GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2019–2026 (USD MILLION)84
TABLE 39NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019–2026 (USD MILLION)84
TABLE 40EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019–2026 (USD MILLION)84
TABLE 41APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019–2026 (USD MILLION)85
TABLE 42LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2019–2026 (USD MILLION)85
7.6OTHER TECHNOLOGIES85
TABLE 43GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2019–2026 (USD MILLION)86
TABLE 44NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION)86
TABLE 45EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION)86
TABLE 46APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION)87
TABLE 47LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2019–2026 (USD MILLION)87
8GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION88
8.1INTRODUCTION89
TABLE 48GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)89
8.2CELL LINE ENGINEERING89
8.2.1INCREASING RESEARCH APPLICATIONS OF CELL LINE ENGINEERING TO PROMOTE MARKET GROWTH89
TABLE 49GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2019–2026 (USD MILLION)90
TABLE 50NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION)90
TABLE 51EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION)90
TABLE 52APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION)91
TABLE 53LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2019–2026 (USD MILLION)91
8.3GENETIC ENGINEERING91
8.3.1ANIMAL GENETIC ENGINEERING91
8.3.1.1Use of animal simulation models in research to increase the demand for genome editing91
8.3.2PLANT GENETIC ENGINEERING92
8.3.2.1Growing attention on GM crops will drive demand for genetic engineering in crops92
TABLE 54GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2019–2026 (USD MILLION)92
TABLE 55NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION)92
TABLE 56EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION)93
TABLE 57APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION)93
TABLE 58LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2019–2026 (USD MILLION)93
8.4DIAGNOSTIC APPLICATIONS94
8.4.1THE GROWING NUMBER OF APPLICATIONS IN DIAGNOSTICS WILL FAVOR MARKET GROWTH94
TABLE 59GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)94
TABLE 60NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)94
TABLE 61EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)95
TABLE 62APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)95
TABLE 63LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)95
8.5DRUG DISCOVERY & DEVELOPMENT96
8.5.1GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH96
TABLE 64GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)96
TABLE 65NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)97
TABLE 66EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)97
TABLE 67APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)97
TABLE 68LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)98
8.6OTHER APPLICATIONS98
TABLE 69GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)98
TABLE 70NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)99
TABLE 71EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)99
TABLE 72APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)99
TABLE 73LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)100
9GENOME EDITING/ GENOME ENGINEERING MARKET, BY END USER101
9.1INTRODUCTION102
TABLE 74GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2019–2026 (USD MILLION)102
9.2PHARMACEUTICAL COMPANIES102
9.2.1CRISPR TECHNOLOGIES ARE USED BY PHARMACEUTICAL COMPANIES FOR APPLICATIONS IN GENE THERAPIES102
TABLE 75GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019–2026 (USD MILLION)102
TABLE 76NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)103
TABLE 77EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)103
TABLE 78APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)103
TABLE 79LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019–2026 (USD MILLION)104
9.3BIOTECHNOLOGY COMPANIES104
9.3.1INCREASING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR MARKET PRODUCTS IN BIOTECH COMPANIES104
TABLE 80GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)104
TABLE 81NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)105
TABLE 82EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)105
TABLE 83APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)105
TABLE 84LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)106
9.4ACADEMIC & GOVERNMENT RESEARCH INSTITUTES106
9.4.1TREND OF COLLABORATIVE RESEARCH WILL SUPPORT MARKET GROWTH106
TABLE 85GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)106
TABLE 86NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION)107
TABLE 87EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION)107
TABLE 88APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)107
TABLE 89LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION,
2019–2026 (USD MILLION)108
10GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION109
10.1INTRODUCTION110
FIGURE 26GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION110
TABLE 90GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2019–2026 (USD MILLION)110
10.2NORTH AMERICA111
FIGURE 27NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT111
TABLE 91NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)112
TABLE 92NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)112
TABLE 93NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)112
TABLE 94NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)113
TABLE 95NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)113
10.2.1US113
10.2.1.1The US dominates the North American market113
TABLE 96US: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)114
TABLE 97US: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)114
TABLE 98US: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)114
TABLE 99US: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)115
10.2.2CANADA115
10.2.2.1Availability of research funding in Canada drives the market growth115
TABLE 100CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)116
TABLE 101CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)116
TABLE 102CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)116
TABLE 103CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)117
10.3EUROPE117
TABLE 104EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)117
TABLE 105EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)118
TABLE 106EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)118
TABLE 107EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)118
TABLE 108EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)119
10.3.1GERMANY119
10.3.1.1Strong academic base and rising awareness are key growth drivers in Germany119
TABLE 109GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)119
TABLE 110GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)120
TABLE 111GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)120
TABLE 112GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 USD MILLION)120
10.3.2UK121
10.3.2.1The UK is the largest market for genome engineering in Europe121
TABLE 113UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)121
TABLE 114UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)121
TABLE 115UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)122
TABLE 116UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)122
10.3.3FRANCE122
10.3.3.1Government funding for genomics and rising investments into research show potential for market growth122
TABLE 117FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)123
TABLE 118FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)123
TABLE 119FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)123
TABLE 120FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)124
10.3.4ITALY124
10.3.4.1Increasing collaborations are driving genomic medicine research, thus, boosting the gene editing market in Italy124
TABLE 121ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)125
TABLE 122ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)125
TABLE 123ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)125
TABLE 124ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 USD MILLION)126
10.3.5SPAIN126
10.3.5.1Proactive research funding by the government to boost the market growth126
TABLE 125SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)126
TABLE 126SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)127
TABLE 127SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)127
TABLE 128SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 USD MILLION)127
10.3.6REST OF EUROPE128
TABLE 129ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)128
TABLE 130ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)128
TABLE 131ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)129
TABLE 132ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)129
10.4ASIA PACIFIC130
FIGURE 28APAC: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT130
TABLE 133APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)131
TABLE 134APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)131
TABLE 135APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)131
TABLE 136APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)132
TABLE 137APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)132
10.4.1CHINA132
10.4.1.1China to hold the largest share of the market in the Asia Pacific132
TABLE 138CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)133
TABLE 139CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)133
TABLE 140CHINA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)133
TABLE 141CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)134
10.4.2JAPAN134
10.4.2.1Focus on cancer research showcases favorable scenarios for the market in Japan134
TABLE 142JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)135
TABLE 143JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)135
TABLE 144JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)135
TABLE 145JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)136
10.4.3INDIA136
10.4.3.1A growing number of startups and government support indicates growth potential136
TABLE 146INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)136
TABLE 147INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)137
TABLE 148INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)137
TABLE 149INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)137
10.4.4ROAPAC138
10.4.4.1The growth of the market in the RoAPAC is attributed to rising genomic Research138
TABLE 150ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)138
TABLE 151ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)138
TABLE 152ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)139
TABLE 153ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)139
10.5REST OF THE WORLD139
10.5.1LATAM139
10.5.1.1The growth of the market in the LATAM is attributed to rising research in genetically modified crops139
TABLE 154LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2019–2026 (USD MILLION)140
TABLE 155LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)140
TABLE 156LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)140
TABLE 157LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)141
TABLE 158LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)141
10.5.1.2Brazil141
10.5.1.2.1The rising number of workshops and conferences are increasing awareness, thus, promoting genome editing advancements141
TABLE 159BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)142
TABLE 160BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)142
TABLE 161BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)142
TABLE 162BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)143
10.5.1.3Rest of LATAM143
10.5.1.3.1Latin America is an attractive market for genomics143
TABLE 163REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)143
TABLE 164REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)144
TABLE 165REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)144
TABLE 166REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET,
BY END USER, 2019–2026 (USD MILLION)144
10.5.2MIDDLE EAST & AFRICA145
10.5.2.1The rising prevalence of genomic disorders in the Middle East and the adoption of genetic testing are driving market growth145
TABLE 167MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)145
TABLE 168MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)146
TABLE 169MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)146
TABLE 170MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION)146
11COMPETITIVE LANDSCAPE147
11.1OVERVIEW147
11.2KEY PLAYERS STRATEGIES/RIGHT TO WIN147
FIGURE 29KEY PLAYERS STRATEGIES IN THE GENOME EDITING/GENOME ENGINEERING MARKET, 2019- 2021147
11.3MARKET SHARE ANALYSIS148
FIGURE 30GENOME EDITING/GENOME ENGINEERING MARKET PLAYER RANKING, 2020148
11.4REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS148
FIGURE 31TOP MARKET PLAYERS DOMINATED THE GENOME EDITING/GENOME ENGINEERING MARKET IN THE LAST THREE YEARS149
11.5COMPANY EVALUATION QUADRANT149
11.5.1STARS149
11.5.2EMERGING LEADERS149
11.5.3PERVASIVE150
11.5.4EMERGING COMPANIES150
FIGURE 32GENOME EDITING/GENOME ENGINEERING MARKET: COMPANY EVALUATION QUADRANT, 2020150
11.6COMPANY EVALUATION QUADRANT: START-UPS/SMES151
11.6.1PROGRESSIVE COMPANIES151
11.6.2STARTING BLOCKS151
11.6.3RESPONSIVE COMPANIES151
11.6.4DYNAMIC COMPANIES151
FIGURE 33GENOME EDITING/GENOME ENGINEERING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020152
11.7COMPANY PRODUCT FOOTPRINT153
TABLE 171PRODUCT PORTFOLIO ANALYSIS: GENOME EDITING/GENOME ENGINEERING MARKET (2020)153
11.8COMPANY GEOGRAPHIC FOOTPRINT154
TABLE 172GEOGRAPHIC REVENUE MIX: GENOME EDITING/GENOME ENGINEERING MARKET (2020)154
11.9COMPETITIVE SCENARIO155
11.9.1SERVICE/ PRODUCT LAUNCHES155
11.9.2DEALS156
11.9.3OTHER DEVELOPMENTS159
12COMPANY PROFILES160
12.1KEY COMPANIES160
(Business overview, Products & Services Offered, Recent developments, MNM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and competitive threats)*
12.1.1THERMO FISHER SCIENTIFIC160
TABLE 173THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW160
FIGURE 34THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)161
12.1.2MERCK KGAA164
TABLE 174MERCK KGAA: BUSINESS OVERVIEW164
FIGURE 35MERCK KGAA: COMPANY SNAPSHOT (2020)164
12.1.3GENSCRIPT167
TABLE 175GENSCRIPT: BUSINESS OVERVIEW167
FIGURE 36GENSCRIPT: COMPANY SNAPSHOT (2020)168
12.1.4SANGAMO THERAPEUTICS171
TABLE 176SANGAMO THERAPEUTICS: BUSINESS OVERVIEW171
FIGURE 37SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2020)171
12.1.5LONZA173
TABLE 177LONZA: BUSINESS OVERVIEW173
FIGURE 38LONZA: COMPANY SNAPSHOT (2020)173
12.1.6EDITAS MEDICINE175
TABLE 178EDITAS MEDICINE: BUSINESS OVERVIEW175
FIGURE 39EDITAS MEDICINE: COMPANY SNAPSHOT (2020)175
12.1.7CRISPR THERAPEUTICS AG177
TABLE 179CRISPR THERAPEUTICS AG: BUSINESS OVERVIEW177
FIGURE 40CRISPR THERAPEUTICS AG: COMPANY SNAPSHOT (2020)177
12.1.8TECAN LIFE SCIENCES179
TABLE 180TECAN LIFESCIENCES: BUSINESS OVERVIEW179
FIGURE 41TECAN LIFESCIENCES: COMPANY SNAPSHOT (2020)180
12.1.9PRECISION BIOSCIENCES181
TABLE 181PRECISION BIOSCIENCES: BUSINESS OVERVIEW181
FIGURE 42PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2020)181
12.1.10AGILENT TECHNOLOGIES183
TABLE 182AGILENT TECHNOLOGIES: BUSINESS OVERVIEW183
FIGURE 43AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)184
12.1.11PERKINELMER186
TABLE 183PERKINELMER: BUSINESS OVERVIEW186
FIGURE 44PERKINELMER: COMPANY SNAPSHOT (2020)187
12.1.12CELLECTIS S.A189
TABLE 184CELLECTIS S.A: BUSINESS OVERVIEW189
FIGURE 45CELLECTIS S.A: COMPANY SNAPSHOT (2020)189
12.1.13INTELLIA THERAPEUTICS191
TABLE 185INTELLIA THERAPEUTICS: BUSINESS OVERVIEW191
FIGURE 46INTELLIA THERAPEUTICS: COMPANY SNAPSHOT (2020)191
12.1.14BLUEBIRD BIO INC.193
TABLE 186BLUEBIRD BIO: BUSINESS OVERVIEW193
FIGURE 47BLUEBIRD BIO: COMPANY SNAPSHOT (2020)193
12.1.15REGENERON PHARMACEUTICALS INC.195
TABLE 187REGENERON PHARMACEUTICALS: BUSINESS OVERVIEW195
FIGURE 48REGENERON PHARMACEUTICALS: COMPANY SNAPSHOT (2020)195
12.2OTHER PLAYERS197
12.2.1SYNTHEGO CORPORATION197
12.2.2VIGENE BIOSCIENCES197

Report Title: Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW